Loading...

IOBT IO BIOTECH INC Investments/Divestments 8-K Filing

BTC

BT

IO BIOTECH INC

(IOBT)

2023 8-K

Show Summary

Show Summary

Financial Statements

Equity Offerings

Financial Update

Nasdaq Compliance Notice

Financing Agreement

Bylaw Amendments

Financial Results

Trial Continuation

Financial Results

Annual Meeting of Stockholders

Financial Results Announcement

Earnings Reports

Participation in Conference

Financial Results and Appoi...

Financial Results and Direc...

Private Placement

Clinical Trial Expansion

Annual Meeting of Stockholders

Earnings Reports

Resignation of Director

Earnings Reports

Results of Operations and F...

Regulation FD Disclosure

Financial Condition

External Links:

IO Biotech, Inc. announced an increase in the number of patients to be enrolled in its Phase 3 clinical trial for IO102-IO103 in combination with pembrolizumab.

AI Assistant

IO BIOTECH INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.